Research Applications for Mirnite 30 mg
Mirnite 30 mg is a tetracyclic antidepressant compound manufactured by Intas Pharmaceuticals, formulated for laboratory research examining noradrenergic and serotonergic receptor systems. Researchers at Stroid UK Shop utilise this compound to investigate the complex mechanisms of neurotransmitter modulation in cellular models. The active pharmaceutical ingredient mirtazapine functions as an antagonist at central alpha-2 adrenergic receptors, facilitating enhanced noradrenergic and serotonergic neurotransmission through presynaptic disinhibition mechanisms.
Molecular Properties and Mechanism
This research compound demonstrates unique pharmacological properties through its interaction with multiple receptor systems. Mirtazapine exhibits antagonism at histamine H1 receptors, serotonin 5-HT2A, 5-HT2C, and 5-HT3 receptors, whilst maintaining minimal direct effects on monoamine reuptake transporters. Research laboratories studying neuropharmacology often examine this compound alongside other investigational materials from our mirtazapine research collection. The tetracyclic structure provides researchers with opportunities to analyse structure-activity relationships in comparison to established research compounds available through our SARMs research portfolio and peptides research catalogue.
Technical Specifications
| Manufacturer | Intas Pharmaceuticals |
|---|---|
| Strength | 30 mg per tablet |
| Active Ingredient | Mirtazapine |
| Molecular Formula | C₁₇H₁₉N₃ |
| Molecular Weight | 265.35 g/mol |
| CAS Registry | 61337-67-5 |
| Storage Requirements | Room temperature, dry environment |
| Research Applications | Neurotransmitter receptor studies |
Laboratory Research Compliance
This compound is supplied exclusively for in-vitro research purposes and laboratory analytical studies. Mirnite 30 mg is not intended for human consumption, clinical applications, or therapeutic use. Research institutions must ensure appropriate safety protocols and disposal procedures when handling this material. All investigators should consult relevant safety data sheets and institutional guidelines before commencing experimental work with this compound.
